Snowball logo
logo
08HH_logo

Shanghai Fosun Pharmaceutical (Group) Co. Ltd

€1.8745€0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
282,725.9324,594.941,399.541,067.241,661.641,855.9
COGS
146,623.3171,114.921,595.321,365.620,800.120,764.8
Gross Profit
136,102.6153,48019,804.219,701.620,861.521,091
Operating Expenses & Income
Operating Income
19,722.926,859.11,563.33,203.13,146.23,247.6
Total Operating Expenses
263,003297,735.839,836.237,864.138,515.538,608.3
R&D Expenses
27,79431,772.24,3463,644.44,012.63,896.5
Selling General & Admin Expenses
72,085.775,028.97,372.96,4736,801.18,961.9
Earnings from Continuing Operations
Interest Expense
(5,962.1)(7,118)(1,324.8)(1,431.9)(1,265.4)(1,240.6)
Interest Income
1,694.22,087.3363.6373.2300.5299.3
Income Tax Expense
7,729.74,630----
Net Income
Net Income
34,323.327,553.12,386.32,769.93,370.63,420.1
Supplemental
EBIT
18,387.925,258.74,589.45,601.26,377.36,591.3
EBITDA
63,139.358,152.57,554.68,602.79,890.46,591.3
In millions of EUR, except % and values per 1 share